Insmed Interest Expense from 2010 to 2024
| INSM Stock | USD 72.27 0.87 1.22% |
Interest Expense | First Reported 2000-03-31 | Previous Quarter 19.9 M | Current Value 20.2 M | Quarterly Volatility 5.3 M |
Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 80.1 M or Total Revenue of 320.5 M, as well as many indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 46.8. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
Insmed | Interest Expense |
Latest Insmed's Interest Expense Growth Pattern
Below is the plot of the Interest Expense of Insmed Inc over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Insmed's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.
| Interest Expense | 10 Years Trend |
|
Interest Expense |
| Timeline |
Insmed Interest Expense Regression Statistics
| Arithmetic Mean | 21,593,120 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 123.32 | |
| Mean Deviation | 20,644,395 | |
| Median | 5,925,000 | |
| Standard Deviation | 26,629,525 | |
| Sample Variance | 709.1T | |
| Range | 80.1M | |
| R-Value | 0.87 | |
| Mean Square Error | 184.7T | |
| R-Squared | 0.76 | |
| Significance | 0.000024 | |
| Slope | 5,184,534 | |
| Total Sum of Squares | 9927.8T |
Insmed Interest Expense History
About Insmed Financial Statements
Insmed investors utilize fundamental indicators, such as Interest Expense, to predict how Insmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Interest Expense | 76.3 M | 80.1 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Insmed Stock
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:Check out the analysis of Insmed Correlation against competitors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.41) | Revenue Per Share 2.224 | Quarterly Revenue Growth 0.17 | Return On Assets (0.25) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.